Role of Taxoids in Head and Neck Cancer

Role of Taxoids in Head and Neck Cancer D. Schrijvers, J.B. Vermorken Oncologist 2000; 5: 199-208 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in head and neck cancers and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Understand the mechanism of action for two important agents in the management of head and neck cancer, docetaxel and paclitaxel. Have reviewed the current status on trials combining these agents with other drugs and radiation in the treatment of head and neck cancer. Be able to select appropriate multidisciplinary approaches related to these agents. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jul. 16, 2002 Most Recent Review: June 10, 2005* Most Recent Update: Jul. 16, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.